Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 2, 2006, Pages 184-191

  Myhrer, Trond ^a   Enger, Siri ^a   Aas, Pål ^a  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ANTICONVULSIVE AGENT; ATROPINE; AVIZAFONE; DIAZEPAM; PENTOBARBITAL; PROCYCLIDINE; SOMAN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; LD 50; LETHALITY; MALE; MORTALITY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; RAT STRAIN; SEIZURE;

ANIMALS; ANTICONVULSANTS; ATROPINE; BRAIN; DIAZEPAM; DIPEPTIDES; DRUG COMBINATIONS; LETHAL DOSE 50; MALE; PENTOBARBITAL; PROCYCLIDINE; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR; SEIZURES; SOMAN;

ANIMALIA;

EID: 33645102686     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_268.x     Document Type: Article

References (36)

1. Aas P. Future considerations for the medical management of nerve agent intoxication Prehosp. Disast. Med. 2003 18 208 216
2. Abraham R. B. V. Rudick A. A. Weinbroum Practical guidelines for acute care of victims of bioterrorism: Conventional injuries and concomitant nerve agent intoxication Anesthesiology 2002 97 989 1004
3. Carpentier P. A. Foquin-Tarricone N. Bodjarian G. Rondouin M. Lerner-Natoli J.-M. Kamenka G. Blanchet M. Denoyer G. Lallement Anticonvulsant and antilethal effects of the phencyclidine derivate TCP in soman poisoning Neurotoxicology 1994 15 837 852
4. Carpentier P. M. Lambrinidis G. Blanchet Early dendritic changes in hippocampal pyramidal neurones (field CA1) of rats subjected to acute soman intoxication: a light microscopic study Brain Res. 1991 541 293 299
5. Churchill L. T. L. Pazdernik R. S. Cross S. R. Nelson F. E. Samson Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors Neurotoxicology 1990 11 57 71
6. Clement J. G. HI-6: Reactivation of central and peripheral acetylcholinersterase following inhibition by soman, sarin and tabun in vivo in the rat Biochem. Pharmacol. 1982 31 1283 1287
7. Clement J. G. B. Broxup Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats Neurotoxicology 1993 14 485 504
8. Cotman C. W. D. T. Monaghan O. P. Ottersen J. Storm-Mathisen Anatomical organization of excitatory amino acid receptors and their pathways Trends Neurosci. 1987 10 273 280
9. Du F. T. Eid E. W. Lothman C. Köhler R. Schwarcz Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy J. Neurosci. 1995 15 6301 6313
10. Hamilton M. G. P. M. Lundy HI-6 therapy of soman and tabun poisoning in primates and rodents Arch. Toxicol. 1989 63 144 149
11. Koplowitz I. R. Menton C. Matthews M. Shutz C. Nalls S. Kelly Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guinea pigs Drug. Chem. Toxicol. 1995 18 119 136
12. Kusic R. B. Boskovic V. Vojvodic D. Janovic HI-6 in man: Blood levels urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers Fund. Appl. Toxicol. 1985 5 S89 S97
13. Lallement G. P. Carpentier A. Collet D. Baubichon I. Pernot-Marino G. Blanchet Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures Neurotoxicology 1992 13 557 568
14. Lallement G. F. Renault D. Baubichon M. Peoc'h M.-F. Burckhart M. Galonnier D. Clarencon, N. Jourdil Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: Relationship to plasmatic benzodiazepine pharmacokinetics Arch. Toxicol. 2000 74 480 486
15. Lallement G. I. Pernot-Marino D. Baubichon, M.-F. Burckhart P. Carpentier G. Blanchet Modulation of soman-induced neuropathology with an anticonvulsant regimen Neuroreport 1994 5 2265 2268
16. McDonough Jr.. J. H. W. Dochterman C. D. Smith T.-M. Shih Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment Neurotoxicology 1995 15 123 132
17. McDonough J. H. Jr.. N. K. Jaax R. A. Crowley M. Z. Mays M. Z. H. E. Modrow Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology Fund. Appl. Toxicol. 1989 13 256 276
18. McDonough Jr.. J. H. T.-M. Shih Pharmacological modulation of soman-induced seizures Neurosci. Biobehav. Rev. 1993 17 203 215
19. McDonough Jr.. J. H. T.-M. Shih Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology Neurosci. Biobehav. Rev. 1997 21 559 579
20. Monaghan D. T. V. R. Holets D. W. Toy C. W. Cotman Anatomical distribution of 4 pharmacologically distinct H-3-labeled L-glutamate binding-sites Nature 1983 306 176 179
21. Myhrer T. J. M. Andersen N. H. T. Nguyen P. Aas Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: Neuropathology and cognitive performance Neurotoxicology 2005 26 39 48
22. Myhrer T. N. H. T. Nguyen J. M. Andersen P. Aas Protection against soman-induced seizures: relationship among doses of prophylactics, soman, and adjuncts Toxicol. Appl. Pharmacol. 2004 196 327 336
23. Myhrer T. L. R. Skymoen P. Aas Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats Neurotoxicology 2003 24 357 367
24. Nash C. B. F. Davis R. A. Woodbury Cardiovascular effects of anesthetic doses of pentobarbital sodium Amer. J. Physiol. 1956 185 107 112
25. Priano L. L. D. L. Traber R. D. Wilson Barbiturate anesthesia: An abnormal physiologic situation J. Pharmacol. Exp. Therap. 1969 165 126 134
26. Schmued L. C. C. Albertson W. Slikker Jr.. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration Brain Res. 1997 751 37 46
27. Schmued L. C. K. J. Hopkins Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration Brain Res. 2000 874 123 130
28. Shih T.-M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning Epilepsy Res. 1990 7 105 116
29. Shih T.-M. T. A. Koviak B. R. Capacio Anticonvulsants for poisoning by the organophosphorous compound soman: pharmacological mechanisms Neurosci. Biobehav. Rev. 1991 15 349 362
30. Siegel S. Nonparametric statistics for the behavioral sciences McGraw-Hill New York 1956
31. Sterri S. H. S. Lyngaas F. Fonnum Toxicity of soman after repetitive injection of sublethal doses in rat Acta pharmacol. et toxicol. 1980 46 1 7
32. Sun M. Z. Chang M. Shau R. Huang T. Chou The mechanism of ageing of phosphonylated acetylcholinesterase Eur. J. Biochem. 1979 100 527 530
33. Taylor P. Anticholinesterase agents In The pharmacological basis of therapeutics Ed Hardman J. G. Limbird L. E. Gilman A. G. McGraw-Hill Companies, Inc. New York 2001 pp. 175 191
34. Thiermann H. S. Seidl P. Eyer HI-6 dimethanesulfonate has better dissolution properties than HI-6 dichloride for application in dry/wet autoinjectors Int. J. Pharmaceut. 1996 137 167 176
35. Van Helden H. P. M. P. M. Herman H. J. Van der Wiel J. De Lang R. W. Busker B. P. C. Melchers O. L. Wolthuis Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys Toxicol. Appl. Pharmacol. 1992 115 50 56
36. Worek F. L. Szinicz Atropine and oxime treatment in lethal soman poisoning of anaesthetized guinea-pigs: HLö 7 dimethanesulfonate versus HI-6 dichloride Pharmacology & Toxicology 1993 72 13 21